NTUS Stock Price, Chart, Stats & News

Natus Medical Incorporated
Save
–
Market cap
86.74x
Current P/E
–
Forward P/E
NTUS chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 57.81% |
Operating margin | 4.48% |
Pretax margin | 4.09% |
Net margin | 2.78% |
Effective tax rate | 31.92% |
ROA | 2.34% |
ROE | 3.15% |
D/E | 0.03x |
Interest coverage ratio | 11.34x |
NTUS valuation
P/E | 86.74x |
P/S | – |
P/B | 2.64x |
P/CF | 17.50x |
P/FCF | – |
P/OCF | 17.50x |
PEG | 0.85x |
EV multiple | 1.30x |
About
Natus Medical Incorporated is a global provider of advanced medical device solutions, dedicated to the diagnosis and treatment of conditions affecting the central nervous and sensory systems. The company's offerings are utilized for the screening, detection, therapeutic intervention, ongoing monitoring, and tracking of a wide array of prevalent medical issues. Its product portfolio addresses critical areas such as newborn care, hearing impairment, neurological and neurosurgical treatments, epilepsy, sleep disturbances, and neuromuscular diseases.
Similar securities
Based on sector and market capitalization
Report issue











